Key result
Hypertrophic cardiomyopathy presents a complex clinical spectrum with varied phenotypes, requiring tailored management to relieve symptoms and prevent disease progression and sudden cardiac death.
Hypertrophic cardiomyopathy presents with a complex clinical spectrum requiring tailored management to relieve symptoms and prevent major cardiovascular complications such as sudden cardiac death.
Individualized echo phenotyping may refine HCM symptom management and SCD risk; leaves open optimal phenotype-specific strategies.
The clinical spectrum of hypertrophic cardiomyopathy (HCM) is complex and includes a variety of phenotypes, which leads to different types of manifestations.Although most of the patients are asymptomatic, a significant proportion of them will develop symptoms or risk of arrhythmias and sudden cardiac death (SCD).Therefore, the objectives of HCM diagnosis and management are to relieve the patients' symptoms (chest pain, heart failure, syncope, palpitations, etc.), prevent disease progression and major cardiovascular complications and SCD.The heterogeneity of HCM patterns, their symptoms and assessment is a challenge for the cardiologist.
No takes yet. Share an insight, caveat, or question.
A 2015 study conducted a review in Hypertrophic cardiomyopathy (HCM). Hypertrophic cardiomyopathy presents a complex clinical spectrum with varied phenotypes, requiring tailored management to relieve symptoms and prevent disease progression and sudden cardiac death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: